Trials / Completed
CompletedNCT04297618
The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- University of Waterloo · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study to evaluate changes in comfort and dryness in symptomatic contact lens (CL) wearers after using Xiidra (lifitegrast 5.0% ophthalmic solution) for 12 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xiidra | Xiidra (lifitegrast 5% ophthalmic solution) |
Timeline
- Start date
- 2021-07-07
- Primary completion
- 2024-04-18
- Completion
- 2024-04-18
- First posted
- 2020-03-05
- Last updated
- 2025-05-04
- Results posted
- 2025-05-04
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04297618. Inclusion in this directory is not an endorsement.